Literature DB >> 26758718

Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy.

M Rico1, E Martínez2, S Pellejero3, B Bermejo4, P Navarrete2, M Barrado2, M Campo2, F Mañeru3, E Villafranca2, J Aristu5.   

Abstract

PURPOSE: In the present study we compared three different Stereotactic body radiation therapy (SBRT) treatment delivery techniques in terms of treatment time (TT) and their relation with intrafraction variation (IFV). Besides that, we analyzed if different clinical factors could have an influence on IFV. Finally, we appreciated the soundness of our margins.
MATERIALS AND METHODS: Forty-five patients undergoing SBRT for stage I lung cancer or lung metastases up to 5 cm were included in the study. All underwent 4DCT scan to create an internal target volume (ITV) and a 5 mm margin was added to establish the planning target volume (PTV). Cone-beam CTs (CBCTs) were acquired before and after each treatment to quantify the IFV. Three different treatment delivery techniques were employed: fixed fields (FF), dynamically collimated arcs (AA) or a combination of both (FA). We studied if TT was different among these modalities of SBRT and whether TT and IFV were correlated. Clinical data related to patients and tumors were recorded as potential influential factors over the IFV.
RESULTS: A total of 52 lesions and 147 fractions were analyzed. Mean IFV for x-, y- and z-axis were 1 ± 1.16 mm, 1.29 ± 1.38 mm and 1.17 ± 1.08 mm, respectively. Displacements were encompassed by the 5 mm margin in 96.1 % of fractions. TT was significantly longer in FF therapy (24.76 ± 5.4 min), when compared with AA (15.30 ± 3.68 min) or FA (17.79 ± 3.52 min) (p < 0.001). Unexpectedly, IFV did not change significantly between them (p = 0.471). Age (p = 0.003) and left vs. right location (p = 0.005) were related to 3D shift ≥2 mm. In the multivariate analysis only age showed a significant impact on the IFV (OR = 1.07, p = 0.007).
CONCLUSIONS: The choice of AA, FF or FA does not impact on IFV although FF treatment takes significantly longer treatment time. Our immobilization device offers enough accuracy and the 5 mm margin may be considered acceptable as it accounts for more than 95 % of tumor shifts. Age is the only clinical factor that influenced IFV significantly in our analysis.

Entities:  

Keywords:  Clinical factors; Intrafraction variation; Lung SBRT; Treatment delivery technique; Treatment time

Mesh:

Year:  2016        PMID: 26758718     DOI: 10.1007/s12094-015-1475-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  27 in total

1.  Daily positioning accuracy of frameless stereotactic radiation therapy with a fusion of computed tomography and linear accelerator (focal) unit: evaluation of z-axis with a z-marker.

Authors:  M Uematsu; M Sonderegger; A Shioda; K Tahara; T Fukui; Y Hama; T Kojima; J R Wong; S Kusano
Journal:  Radiother Oncol       Date:  1999-03       Impact factor: 6.280

2.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

3.  Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study.

Authors:  Ronald C McGarry; Lech Papiez; Mark Williams; Tia Whitford; Robert D Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-22       Impact factor: 7.038

4.  Stereotactic radiotherapy using tomotherapy for early-stage non-small cell lung carcinoma: analysis of intrafraction tumour motion.

Authors:  Drexell Hunter Boggs; Steven Feigenberg; Robert Walter; Dennis Wissing; Bijal Patel; Terry Wu; Lane Rosen
Journal:  J Med Imaging Radiat Oncol       Date:  2014-04-27       Impact factor: 1.735

5.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

6.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer.

Authors:  Frank J Lagerwaard; Cornelis J A Haasbeek; Egbert F Smit; Ben J Slotman; S Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

7.  Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy.

Authors:  Inga S Grills; Geoffrey Hugo; Larry L Kestin; Ana Paula Galerani; K Kenneth Chao; Jennifer Wloch; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-29       Impact factor: 7.038

8.  Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.

Authors:  Inga S Grills; Victor S Mangona; Robert Welsh; Gary Chmielewski; Erika McInerney; Shannon Martin; Jennifer Wloch; Hong Ye; Larry L Kestin
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

9.  Factors influencing intrafractional target shifts in lung stereotactic body radiation therapy.

Authors:  Hong-Wei Liu; Rao Khan; Zoann Nugent; Krista Krobutschek; Peter Dunscombe; Harold Lau
Journal:  Pract Radiat Oncol       Date:  2013-04-09

10.  Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results.

Authors:  Fumiya Baba; Yuta Shibamoto; Natsuo Tomita; Chisa Ikeya-Hashizume; Kyota Oda; Shiho Ayakawa; Hiroyuki Ogino; Chikao Sugie
Journal:  Radiat Oncol       Date:  2009-05-28       Impact factor: 3.481

View more
  1 in total

1.  Influence of Clinical and Tumor Factors on Interfraction Setup Errors With Rotation Correction for Vacuum Cushion in Lung Stereotactic Body Radiation Therapy.

Authors:  Hua Chen; Lingxiang Liu; Hao Wang; Yan Shao; Hengle Gu; Yanhua Duan; Aihui Feng; Ying Huang; Zhiyong Xu
Journal:  Front Oncol       Date:  2021-10-21       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.